Spero Therapeutics
SPRO
SPRO
50 hedge funds and large institutions have $143M invested in Spero Therapeutics in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $29K
Holders
50
Holding in Top 10
1
Calls
–
Puts
$29K
Top Buyers
| 1 | +$203K | |
| 2 | +$127K | |
| 3 | +$105K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$47.4K |
| 5 |
Millennium Management
New York
|
+$42.9K |
Top Sellers
| 1 | -$89.2K | |
| 2 | -$69.4K | |
| 3 | -$43.5K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$39.4K |
| 5 |
HF
HRT Financial
New York
|
-$22K |